Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: T2 Results ...

Aug 16, 2012 01:54AM

opc
Aug 16, 2012 02:10AM

Aug 16, 2012 09:52AM

U,

I should add this:

Al:

"The last patient first visit for the 175 trial is also on track with the revised schedule, thus both trials are expected to be completed in the second quarter of next year with resubmission of the NDA in Q3."

http://seekingalpha.com/article/792571-mannkind-s-ceo-discusses-q2-2012-results-earnings-call-transcript?find=type%20II&all=false

1
opc
Aug 16, 2012 11:18AM
Share
New Message
Please login to post a reply